CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Unregistered share sale · Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- CT ORDER Other Confidential Order
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Material agreement · Agreement ended · Unregistered share sale
- 424B5 Offering Prospectus
- 8-K Event Other events
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes Chief Financial Officer gave up 8,192 shares (to pay taxes)
- DEFA14A Proxy Proxy Materials
Page 25 of 33 · 652 filings